Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 07-2020 | 06-2020 | 04-2020 | 03-2020 | 07-2019 | |
| Operating Expenses | 1,318 | 0 | 0 | 0 | 0 |
| Operating Income | -1,318 | N/A | N/A | N/A | N/A |
| Other Income | 2 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -1,317 | 0 | 0 | 0 | 0 |
| Net Income Continuous | -1,317 | N/A | N/A | N/A | N/A |
| Net Income | $-1,317 | $N/A | $N/A | $N/A | $N/A |
| EPS Basic Total Ops | -26.99 | N/A | N/A | N/A | N/A |
| EPS Basic Continuous Ops | -24.59 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -26.99 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -24.59 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,318 | $N/A | $N/A | $N/A | $N/A |